Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-03-22
1997-06-03
Feisee, Lila
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
5303877, 53038823, 5303873, 530350, 530351, C07K 1624, C07K 1452, C12P 2108, G01N 3353
Patent
active
056353561
ABSTRACT:
The present invention relates, in general, to oncoimmunins. In particular, the present invention relates to antibodies that specifically bind to a tumor-derived Oncoimmunin-myeloid (OI-M) factor that induces differentiation of myeloid cells. The invention also provides methods of detecting OI-M factors utilizing OI-M specific antibodies and immunodetection kits.
REFERENCES:
patent: 4496658 (1985-01-01), Kondo et al.
patent: 4863727 (1989-09-01), Zimmerman
patent: 5154921 (1992-10-01), Sager et al.
patent: 5364619 (1994-11-01), Packard et al.
patent: 5370991 (1994-12-01), Remold-O'Donnell
Packard, B.S., et al., "Identification of a New Growth Factor for Lymphocytes: Mitogenic Stimulation of Lymphocytes by Tumor Cell Lines," Federation of American Society of Experimental Biology, (Apr. 1991) Atlanta, GA.
Packard, B.S., "Identification of a New Class of Growth Factors: Tumor-Derived Lymphocytes Mitogens," Biophysical Society of America, (Feb. 1991) San Francisco, CA.
Packard, B.S., "Mitogenic Stimulation of Human T Cells by Solid Tumor Lines Mediated by Secreted Proteins," Biophysical Society of America, (Feb. 1990) Baltimore, MD.
Packard, B.S., "Mitogenic Stimulation of Human Tumor Infiltrating Lymphocytes by Human Cell Lines," American Assoc. of Cancer Research, (May 1990) Washington, D.C.
Packard, B.S., et al., "Mitogenic Stimulation of Human Tumor Infiltrating Lymphocytes by Human Cell Lines," (Mar. 1990) Florence, Italy.
Packard, B.S., "A New Mitogen Derived From a Tumor Cell Line for Tumor Infiltrating Lymphocytes (TILS)," American Society of Cell Biology, (Nov. 1989) Houston, TX.
Packard, B.S., "A New Mitogen for Tumor Infiltrating Lymphocytes (TILS) Derived From a Tumor Cell Line," (Nov. 1989) Hilton Head, SC.
Packard, B.S., "Mitogenic Stimulation of Human T Cells by Solid Tumor Lines Mediated by Secreted Proteins," (Jul. 1989) Berlin, West Germany.
Treves, A. J. et al., "Immunotherapy of Lethal Metastases by Lymphocytes Sensitized Against Tumor Cells In Vitro", J. Natl. Cancer Inst. 54: 777-780 (1975).
Lee, S.K., et al., "Autologous Leukemia-Specific T-Cell-Mediated Lymphocytotoxicity in Patients with Acute Myelogenous Leukemia," J. Exp. Med. 147: 912-922 (1978).
Zarling, J.M., et al., "Continuous Culture of T Cells Cytotoxic for Autologous Human Leukemia Cells," Nature (London), 280: 685-687 (1979).
Vose, B.M., et al., "Human Tumour Antigens Defined by Cytotoxicity and Proliferative Responses of Cultured Lymphoid Cells," Nature (London), 296: 359-361 (1982).
Vose, B.M., et al., "Specific Cytotoxicity Against Autologous Tumour and Proliferative Responses of Human Lymphocytes Grown in Interleukin 2," Inst. J. Cancer, 29: 33-39 (1982).
Vanky, F., et al., "Lysis Tumor Biopsy Cells by Autologous T Lymphocytes Activated in Mixed Cultures and Propagated with T Cell Growth Factor," J. Exp. Med., 155: 83-95 (1982).
Mitsuya, et al., "Generation of an HLA-Restricted Cytotoxic T Cell Line Reactive Against Cultured Tumor Cells From a Patient Infected with Human T Cell Leukemia/Lymphoma Virus," J. Exp. Med., 158: 994-999 (1983).
De Vries, J.E., et al., "Cloned Human Cytotoxic T Lymphocyte (CTL) Lines Reactive With Autologous Melanoma Cells," J. Immunol., 132: 510-519 (1984).
Slovin, S.F., et al., "Cellular Immune Response to Human Sarcomas: Cytotoxic T. Cell Clones Reactive with Autologous Sarcomas," J. Immunol., 137: 3042-3048 (1986).
Itoh, K., et al., "Interleukin 2 Activation of Cytotoxic T-Lymphocytes Infiltrating into Human Metastatic Melanomas," Cancer Res. 46: 3011-3017 (1986).
Rosenberg, et al., "A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes," Science 233: 1318-1321 (1986).
Rabinowich, H., et al., "Functional Analysis of Mononuclear Cells Infiltrating into Tumors: Lysis of Autologous Human Tumor Cells by Cultured Infiltrating Lymphocytes," Cancer Res. 47: 173-177 (1987).
Miescher, T., et al., "Clonal and Frequency Analyses of Tumor-Infiltrating T Lymphocytes From Human Solid Tumors," J. Immunol. 138: 4004-4011 (1987).
Kradin, R.L., et al., "Tumor-Derived Interleukin-2-Dependent Lymphocytes in Adoptive Immunotherapy of Lung Cancer," Cancer Immunol. Immunother. 24: 76-85 (1987).
Rosenberg, S.A., et al., "Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma," New Engl. J. Med. 319: 1676-1680 (1988).
Smith, K.A., "Interleukin-2: Inception, Impact, and Implications," Science, 240: 1169-1176 (1988).
Topalian, S.L., et al., "Expansion of Human Tumor Infiltrating Lymphocytes for Use in Immunotherapy Trials," J. Immunol. Meth. 102: 127-141 (1987).
Packard, B.S., "Identification of a Synthetic Nonapeptide Sequence that Inhibits Motility in Culture of a Melanoma Subclone that Possesses a High Metastatic Potential," Proc. Natl. Acad. Sci. USA, Cell Biology, 84: 9015-9019 (1987).
Kirnbauer, R., et al., "IFN-.beta.2 Cell Differentiation Factor 2, or Hybridoma Growth Factor (IL-6) is Expressed and Released by Human Epidermal Cells and Epidermoid Carc" J. Immunol., 142: 1922-1928 (1989).
Packard, B.S., "The Use of Tumor-Infiltrating Lymphocytes in Cancer Therapy", Progress in Regional Cancer Therapy, Jackez, R. et al., eds., Springer, Heidelberg, (1990) pp. 293-303.
Smith, K.A., "The Interleukin 2 Reporter," Adv. Immunol., 42: 165-179 (1988).
Quinan, C.V., "Points to Consider in the Collection, Processing, and Testing of Ex Vivo Activated Mononuclear Leukocytes for Administration to Humans", Publication of Center for Biologics Evaluation and Research, Food and Drug Administration (1989).
Andreesen, R., et al., Pathobiology, 59: 259-263 (1991).
Bartholeyns, et al., Anticancer Res. 11: 1201-1204 (1991).
Andreesen, et al., Cancer Detection and Prevention, 15: 413-421 (1991).
Packard, B.Z. et al., Journal of Biological Chemistry, 268:9 6356-6363 (Mar. 25, 1993).
Remold-O'Donnell, E., et al., Proc. Natl. Acad. Sci. USA, Biochemistry, : 5635-5639 (Jun. 1992).
Zou, Z. et al., Science, 263: 526-529 (Jan. 28, 1994).
Packard, B.S., "Mitogenic Stimulation of Human Tumor-Infiltrating Lymphocytes by Secreted Factor(s) from Human Tumor Cell Lines," Proc. Natl. Acad. Sci. USA, (1990) vol. 87, pp. 4058-4062.
Packard, B.Z., et al., "Oncoimmunin-L, A 45-Kilodalton Protein with Lymphoid Immunomodulatory Activity: Mitogenic Stimulation of Human Tumor Infiltrating Lymphyocytes," FASEB Journal 8:(7) (Apr. 1994): p. A1460.
Packard, B.Z., "Induced Integrin Cell Surface Expression and Chemotactic Responsiveness by Oncoimmunin-M," Biophysical Journal 66(2, part 2):A172, 1994.
Packard, B.Z., et al., "Immunotherapy Without MHC Restriction," Growth Factors and Medical Oncology, Rimini, Italy (Jun. 1993).
Packard, B.Z., et al., "Oncoimmunin-M (OI-M) Induces Human Leukemic Cell (HL-60) Motility to Human C5a," Biophysical J. 64(2 part 2): A368, 1993.
Packard, B.S., et al., "Oncoimmunins: New Tumor-Derived Factors with Potential Immunomodulatory Activities," Am. Soc. Hematol. (Dec. 1992).
Packard, B.Z., "Oncoimmunins: New Tumor-Derived Cytokines with Immunomodulatory Activity," Am. Assoc. Immunol., Anaheim, CA (Apr. 1992).
Packard, B.Z., "Oncoimmunins: New Tumor-Derived Cytokines with Immunomodulatory Activity," Biophysical J. 61(2 part 2):A48, 1992.
Packard, B.Z., "Oncoimmunin: A New Tumor-Derived Cytokine with Immunostimulatory Activity," J. Cell. Biol. 115(3, part 2):423A, 1991.
Packard, B.S., et al., "Oncoimmunins: New Tumor-Derived Factors with Immunomodulatory Activity," FASEB J. 6(5):A1695, 1992.
Roitt (1991) "Essential Immunology", Blackwell Scientific Publication, Oxford, pp. 65-68 & 74.
Sass et al (1989) J. Biol. Chem. 264(7): 4076-4081.
Intelligenetics Fast DB 5.4 Sequence Comparison, PIR 43 Databank, #A 32957.
Pan et al (1989) Histochemical J. 21: 638-644.
Cuhhajlani et al (1984) Leukemia Res. 8(6): 985-995.
Komoriya Akira
Packard Beverly
Feisee Lila
Lucas John
The United States of America as represented by the Department of
LandOfFree
Anti-oncoimmunin-M antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-oncoimmunin-M antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-oncoimmunin-M antibodies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-390566